185 related articles for article (PubMed ID: 38048459)
1. Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation.
Dijkstra DJ; van de Bovenkamp FS; Abendstein L; Zuijderduijn R; Pool J; Kramer CSM; Slot LM; Drijfhout JW; de Vor L; Gelderman KA; Rooijakkers SHM; Zaldumbide A; Vidarsson G; Sharp TH; Parren PWHI; Trouw LA
Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2310666120. PubMed ID: 38048459
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
Antes U; Heinz HP; Loos M
Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
[TBL] [Abstract][Full Text] [Related]
3. Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus.
Kleer JS; Rabatscher PA; Weiss J; Leonardi J; Vogt SB; Kieninger-Gräfitsch A; Chizzolini C; Huynh-Do U; Ribi C; Trendelenburg M
Front Immunol; 2021; 12():761395. PubMed ID: 35087514
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
[TBL] [Abstract][Full Text] [Related]
5. [Autoantibodies against the complement component C1q in systemic lupus erythematosus].
Antes U; Heinz HP; Hartung K; Loos M
Klin Wochenschr; 1990 Nov; 68(21):1066-70. PubMed ID: 2084321
[TBL] [Abstract][Full Text] [Related]
6. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
Wisnieski JJ; Jones SM
J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
[TBL] [Abstract][Full Text] [Related]
7. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
Antes U; Heinz HP; Loos M
J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.
Uwatoko S; Mannik M
J Clin Invest; 1988 Sep; 82(3):816-24. PubMed ID: 3262124
[TBL] [Abstract][Full Text] [Related]
9. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
[TBL] [Abstract][Full Text] [Related]
10. Western blot analysis of human IgG reactive with the collagenous portion of C1q: evidence of distinct binding specificities.
Mårtensson U; Sjöholm AG; Sturfelt G; Truedsson L; Laurell AB
Scand J Immunol; 1992 Jun; 35(6):735-44. PubMed ID: 1604245
[TBL] [Abstract][Full Text] [Related]
11. The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes.
Kishore U; Sontheimer RD; Sastry KN; Zappi EG; Hughes GR; Khamashta MA; Reid KB; Eggleton P
Clin Exp Immunol; 1997 May; 108(2):181-90. PubMed ID: 9158084
[TBL] [Abstract][Full Text] [Related]
12. C1q A08 Is a Half-Cryptic Epitope of Anti-C1q A08 Antibodies in Lupus Nephritis and Important for the Activation of Complement Classical Pathway.
Wu WJ; Tan Y; Liu XL; Yu F; Zhao MH
Front Immunol; 2020; 11():848. PubMed ID: 32536911
[TBL] [Abstract][Full Text] [Related]
13. C1q: a multifunctional ligand for a new immunoadsorption treatment.
Hiepe F; Pfüller B; Wolbart K; Bruns A; Leinenbach HP; Hepper M; Schössler W; Otto V
Ther Apher; 1999 Aug; 3(3):246-51. PubMed ID: 10427623
[TBL] [Abstract][Full Text] [Related]
14. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus.
Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
Clin Exp Immunol; 1987 Jul; 69(1):98-106. PubMed ID: 3498589
[TBL] [Abstract][Full Text] [Related]
15. C1q, antibodies and anti-C1q autoantibodies.
Beurskens FJ; van Schaarenburg RA; Trouw LA
Mol Immunol; 2015 Nov; 68(1):6-13. PubMed ID: 26032012
[TBL] [Abstract][Full Text] [Related]
16. Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP.
Radanova M; Vasilev V; Deliyska B; Kishore U; Ikonomov V; Ivanova D
Immunobiology; 2012 Jul; 217(7):684-91. PubMed ID: 22209113
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases.
Wener MH; Uwatoko S; Mannik M
Arthritis Rheum; 1989 May; 32(5):544-51. PubMed ID: 2785797
[TBL] [Abstract][Full Text] [Related]
18. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
Pang Y; Yang XW; Song Y; Yu F; Zhao MH
Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
[TBL] [Abstract][Full Text] [Related]
19. C1q, autoimmunity and apoptosis.
Botto M; Walport MJ
Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven.
Schaller M; Bigler C; Danner D; Ditzel HJ; Trendelenburg M
J Immunol; 2009 Dec; 183(12):8225-31. PubMed ID: 20007586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
